Back

Impact of M-TEER on health status in patients with moderate-to-severe functional mitral regurgitation and heart failure: results from RESHAPE-HF2

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Registries and clinical trials: new onset and chronic heart failure Treatment HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

6 More presentations in this session

Presentation thumbnail
Discussant panel
Presentation thumbnail
Primary results of TITRATE-HF: 1-year continuous GRMT implementation, prognosis, and LVEF improvement in de novo heart failure with reduced ejection fraction
Professor J. Brugts (Rotterdam, NL)
Slides Video
Presentation thumbnail
Sudden cardiac arrest in patients with newly diagnosed NICM or MI/CAD - nationwide analysis of >19.000 patients with a WCD
Professor J. Bauersachs (Hannover, DE)
Slides Video
Presentation thumbnail
Digoxin lowers pulmonary artery pressures and heart rate in patients with heart failure and reduced ejection fraction
Professor J. Lindenfeld (Nashville, US)
Slides Video
Presentation thumbnail
Increased perirenal adipose tissue thickness is associated with autonomic dysfunction and reduced CGRP in patients with HFpEF: a prospective observational study
Doctor O. Polat (Afyonkarahisar, TR)
Slides Video

Access the full session

Session thumbnail
Registries and clinical trials: new onset and chronic heart failure
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Session
Quality-of-life and patient reported outcomes: from clinical trials to clinical practice
thumbnail
Congress Session
Late breaking clinical trials: further analyses and baseline characteristics
thumbnail
Congress Session
Late breaking clinical trials II

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources